City of Hope Medical Center: all 674 studies

Page 5 of 7. Open to participants first (178), then studies with results posted, then the rest; newest registration first within each.

• Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver CancerActive, not recruitingNCT04605731Phase 1
• 64Cu-DOTA-pembrolizumab PET for the Study of PD1 ExpressionWithdrawnNCT04605614Phase 1
• An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 DiabetesActive, not recruitingNCT04590872Phase 1
• LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung CancerActive, not recruitingNCT04560972Phase 1
• Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer SurvivorsWithdrawnNCT04560439Not applicable
• Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST StudyActive, not recruitingNCT04537871
• White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CASuspendedNCT04519879Phase 2
• Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesCompletedNCT04501913
• Analysis of Coronavirus Disease 19 (COVID-19) Convalescent PlasmaActive, not recruitingNCT04497779
• Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed or Refractory Mantle Cell LymphomaActive, not recruitingNCT04484012Phase 2
• Remotivation Process for Improving Adherence to Lymphedema Treatment Programs in Patients With Breast Cancer-Related LymphedemaCompletedNCT04465253Not applicable
• Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal CancerActive, not recruitingNCT04428905Phase 3
• TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic SclerosisActive, not recruitingNCT04380831Early Phase 1
• Leflunomide for the Treatment of High-Risk Smoldering Multiple MyelomaActive, not recruitingNCT04370483Early Phase 1
• Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal CancerCompletedNCT04362839Phase 1
• Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH StudyActive, not recruitingNCT04358276Not applicable
• Impact of the Therapeutic Alliance on Reduction of Disparities in Latino End-of-Life Cancer CareCompletedNCT04342611
• TBI Using IMRT (VMAT or Tomotherapy) for the Prevention of Pul Toxicities in Patients Undergoing Donor SCTActive, not recruitingNCT04281199Phase 1
• Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute LeukemiaActive, not recruitingNCT04262843Phase 2
• Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLCActive, not recruitingNCT04227028Phase 1
• 68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate CancerCompletedNCT04216134Phase 1
• Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive GlioblastomaActive, not recruitingNCT04214392Phase 1
• Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host DiseaseActive, not recruitingNCT04212416Phase 1
• Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell TransplantActive, not recruitingNCT04177004Phase 1
• Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell TransplantActive, not recruitingNCT04160390
• Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic CancerSuspendedNCT04158635Phase 1
• Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family CaregiversWithdrawnNCT04085081Not applicable
• Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With CancerCompletedNCT04014231
• IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBMActive, not recruitingNCT04003649Phase 1
• Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing SurgeryActive, not recruitingNCT03997162
• An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal CancerCompletedNCT03993327Phase 1
• Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid CancerSuspendedNCT03975231Phase 1
• Perioperative Ostomy Self-Management Telehealth for Cancer Patients and Family CaregiversCompletedNCT03970070Phase 2
• Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or RefractorySuspendedNCT03969446Phase 1
• Leflunomide in Treating Patients With High-Risk Smoldering Multiple MyelomaWithdrawnNCT03952832Phase 2
• CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell TransplantActive, not recruitingNCT03922035Phase 1
• Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their CaregiversCompletedNCT03902535
• Copanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin LymphomaActive, not recruitingNCT03884998Phase 1
• Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint DiseaseActive, not recruitingNCT03865992Not applicable
• CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney CancerCompletedNCT03829111Phase 1
• Psycho-Educational Cognition Intervention in Patients With Blood and Lymph CancerWithdrawnNCT03804164Not applicable
• Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood CancerWithdrawnNCT03739606Phase 2
• Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 MutationSuspendedNCT03728335Phase 2
• Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin LymphomaActive, not recruitingNCT03712202Phase 2
• CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple MyelomaSuspendedNCT03710421Phase 1
• HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal MetastasesActive, not recruitingNCT03696030Phase 1
• Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell DiseaseActive, not recruitingNCT03664830Phase 1
• Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal TherapyCompletedNCT03661437Early Phase 1
• IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver CancerActive, not recruitingNCT03655002Phase 1
• Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal CancerWithdrawnNCT03592407Phase 2
• Daratumumab, Bortezomib, Dexamethasone, Pegylated Liposomal Doxorubicin Hydrochloride, and Lenalidomide in Treating Participants With Plasma Cell LeukemiaWithdrawnNCT03591744Phase 1
• 64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing MastectomyCompletedNCT03542695Early Phase 1
• Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantWithdrawnNCT03531281Phase 1
• Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic LeukemiaActive, not recruitingNCT03512405Phase 1/2
• Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic SyndromeSuspendedNCT03494569Phase 1
• Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin LymphomaActive, not recruitingNCT03479268Phase 1
• Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid LeukemiaActive, not recruitingNCT03467386Phase 1
• Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell LymphomaCompletedNCT03440567Phase 1
• Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell TransplantWithdrawnNCT03438344Phase 2
• Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and ChemotherapyActive, not recruitingNCT03422731Early Phase 1
• ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung CancerWithdrawnNCT03402880Phase 2
• Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV GliomaActive, not recruitingNCT03389230Phase 1
• Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell LymphomasWithdrawnNCT03373305Phase 1
• Daratumumab After Stem Cell Transplant in Treating Patients With Multiple MyelomaActive, not recruitingNCT03346135Phase 2
• Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by SurgeryCompletedNCT03317119Phase 1
• Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple MyelomaCompletedNCT03311828Phase 1
• Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer PatientsActive, not recruitingNCT03303846Not applicable
• Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family CaregiversCompletedNCT03267524Not applicable
• A Blood Stem Cell Transplant for Sickle Cell DiseaseActive, not recruitingNCT03249831Phase 1
• Education as an Intervention of Compassion FatigueCompletedNCT03212417Not applicable
• High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic LymphomaActive, not recruitingNCT03178617Not applicable
• Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary MyelofibrosisActive, not recruitingNCT03118492Phase 1
• Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by SurgeryWithdrawnNCT03117855Phase 1
• Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple MyelomaWithdrawnNCT03100877Phase 1/2
• Comic Art Creation as Supportive Care in Cancer Patients and CaregiversCompletedNCT03067766Not applicable
• Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer SurvivorsCompletedNCT03063918Not applicable
• Long-Term Follow-Up in Patients With Prostate Cancer After SurgeryCompletedNCT03035500Not applicable
• Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin LymphomaCompletedNCT03013933Phase 1
• Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid LeukemiaCompletedNCT03009240Phase 1
• Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the LiverCompletedNCT03005002Phase 1
• Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast CancerCompletedNCT02996825Phase 1
• Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic LeukemiaCompletedNCT02948283Phase 1
• Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With MyelofibrosisCompletedNCT02917096Phase 1
• An Exercise Intervention Trial to Reduce Symptoms & Improve Clinical Outcomes of Platinum-Based Treatment in Ovarian Cancer PatientsWithdrawnNCT02878980Not applicable
• COMFORT Caregiver Intervention in Improving Communication and Reducing Distress in Caregivers of Patients With Lung CancerCompletedNCT02603367Not applicable
• Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive EffectsCompletedNCT02559557Not applicable
• Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With MyelofibrosisWithdrawnNCT02528877Phase 1
• Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With CancerActive, not recruitingNCT02517034Not applicable
• Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable CommunitiesActive, not recruitingNCT02513407Not applicable
• Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing SurgeryCompletedNCT02511821Not applicable
• Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected PatientsActive, not recruitingNCT02500849Phase 1
• Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute LeukemiaCompletedNCT02446964Phase 1
• Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior TherapyActive, not recruitingNCT02432963Phase 1
• Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast CancerCompletedNCT02432950Not applicable
• Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their CaregiversTerminatedNCT02412124Not applicable
• PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare ProvidersCompletedNCT02408406Not applicable
• Video-Assisted Intervention in Improving Recovery in Patients With Cancer Undergoing Lung Surgery and CaregiversCompletedNCT02345798Not applicable
• Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin LymphomaCompletedNCT02342782Phase 1
• Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain TumorsCompletedNCT02338037Early Phase 1
• Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin LymphomaActive, not recruitingNCT02337985Phase 1

← City of Hope Medical Center overview and focus areas